Johnson & Johnson in Phase 3 of one-dose vaccine trial
Johnson & Johnson is in the third phase of trials for a coronavirus vaccine that would take only a single dose.
Johnson & Johnson is in the third phase of trials for a coronavirus vaccine that would take only a single dose.